Brooks Laboratories IPO listing price is ₹ 60.20, issue price is ₹ 100.00, and currently trading at ₹ 152.78 as on August 7, 2025. Brooks Laboratories IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Brooks Laboratories IPO is a Book Building listing on BSE,NSE exchange. The company is based in Punjab and caters to Pharmaceutical sector. D And A Financial Services is the merchant banker of Brooks Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th November 2010.
Brooks Laboratories IPO offer price is ₹ 100.00 and got listed at ₹ 60.20. Read Brooks Laboratories IPO details mentioned above.The IPO of Brooks Laboratories Limited was listed on 5th September 2011. As of today, Brooks Laboratories IPO is trading at ₹ 152.78, compared to the previous day’s close of ₹ 151.65. Read the report above for detailed IPO performance.
The issue price of Brooks Laboratories IPO was ₹ 100.00 per equity share.
Brooks Laboratories IPO was listed at ₹60.20 on the stock exchange on 5th September 2011. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of August 7, 2025, the current market price of Brooks Laboratories IPO is ₹ 152.78.
The 52-week high for Brooks Laboratories IPO is ₹ 198.86, while the 52-week low is ₹ 94.42. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Brooks Laboratories IPO listed at ₹ 60.20 against the issue price of ₹ 100.00 per equity share, showing a listing day gain/loss of -39.8 (-39.80%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Brooks Laboratories IPO stock moved from its listing price of ₹ 60.20 to the current price of ₹152.78 per equity share, reflecting a change of 153.79% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Brooks Laboratories IPO issue date of 5th September 2011 and CMP of ₹152.78, the estimated CAGR is approximately 3.09%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Brooks Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Brooks Laboratories Financial Review Page
Merchant Banker(s) of Brooks Laboratories IPO: D And A Financial Services Private Limited
Brooks Laboratories IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Brooks Laboratories IPO listed at a listing price of 60.20 against the offer price of 100.00.
The current market price of Brooks Laboratories is 152.78.
Why Us?